Time-Related Changes in Yield and Harms of Screening Breast Magnetic Resonance Imaging.
暂无分享,去创建一个
Stephen R Grobmyer | Colin O'Rourke | J. Crowe | R. Patrick | S. Grobmyer | H. Pederson | J. Lyons | C. O'rourke | Joseph P Crowe | Joanne Lyons | Holly J Pederson | Rebecca J Patrick | C. O'Rourke
[1] L. Liberman,et al. Breast MRI screening of women with a personal history of breast cancer. , 2010, AJR. American journal of roentgenology.
[2] Kevin Hughes,et al. Predicting the survival of patients with breast carcinoma using tumor size , 2002, Cancer.
[3] Etta D Pisano,et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. , 2012, JAMA.
[4] Focusing on Breast Cancer Overdiagnosis and Overtreatment: The Promise of Molecular Medicine , 2013, The breast journal.
[5] Ellen Warner,et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.
[6] Laura Cortesi,et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. , 2007, Radiology.
[7] M. Yaffe,et al. Long-term results of screening with magnetic resonance imaging in women with BRCA mutations , 2012, British Journal of Cancer.
[8] Maximilian Reiser,et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] C. Gatsonis,et al. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers , 2012, Cancer.
[10] S. Plevritis,et al. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma , 2004, Cancer.
[11] H. Nelson,et al. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.
[12] Barbara L. Smith,et al. The effect of tumor size and lymph node status on breast carcinoma lethality , 2003, Cancer.
[13] Ellen Warner,et al. MRI surveillance for hereditary breast-cancer risk , 2005, The Lancet.
[14] Use of Breast MRI Surveillance in Women at High Risk for Breast Cancer: A Single-Institutional Experience , 2010, Annals of Surgical Oncology.
[15] J. Wise. Mammography results in substantial overdiagnosis of breast cancer, concludes study , 2012, BMJ : British Medical Journal.
[16] Constantine Gatsonis,et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging , 2005, Cancer.
[17] D Krebs,et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. , 2000, Radiology.
[18] M. Graber,et al. Does screening mammography lead to overdiagnosis of invasive breast cancer? , 2013, American family physician.
[19] J. Austoker,et al. What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Ingvar Andersson,et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.
[21] Michael Waller,et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial , 2006, The Lancet.
[22] Karel G M Moons,et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.
[23] Kjell Arne Kvistad,et al. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. , 2007, Breast.
[24] R. Fimmers,et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Linda Humphrey,et al. Appropriate Use of Screening and Diagnostic Tests to Foster High-Value, Cost-Conscious Care , 2012, Annals of Internal Medicine.
[26] G. Hortobagyi,et al. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer , 2011, Cancer.
[27] P. Chappuis,et al. Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.
[28] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[29] H. D. de Koning,et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.
[30] T. To,et al. The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years , 2002, Annals of Internal Medicine.
[31] H. Gilbert Welch,et al. Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence , 2013 .
[32] H. D. de Koning,et al. Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial , 2012, BMC Cancer.
[33] C. Gatsonis,et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.
[34] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .
[35] Douglas K Owens,et al. High-Value, Cost-Conscious Health Care: Concepts for Clinicians to Evaluate the Benefits, Harms, and Costs of Medical Interventions , 2011, Annals of Internal Medicine.